My clinical friends in ortho are going to hate this topic. We are going to talk about an uncomfortable aspect of our industry, give an example of a proper clinical study, then open comments on how to fix this problem.
The Premise Clinical data in Orthopedics is always fake...1) if there is a pre-determined purpose for the study (eg: this device/treatment works than that one) 2) and if the study is paid for by single entity (hospital group or manufacturer).
Reliable clinical data should be our North Star in orthopedics. Yet, a closer look reveals a persistent challenge: bias in research, particularly from industry funding. Studies consistently show that industry-sponsored orthopedic trials are more likely to report positive results, potentially skewing perceptions of efficacy. This isn't to say that data is fabricated—far from it—but preconceived objectives or single-entity funding (e.g., from manufacturers) can introduce subtle influences on study design, comparator selection, or reporting. Conflicts of interest appear in up to 88% of such studies, amplifying the need for transparency. The good news? High-quality, independent randomized controlled trials (RCTs)—especia...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !

